Literature DB >> 19767382

Using National Drug Codes and drug knowledge bases to organize prescription records from multiple sources.

Linas Simonaitis1, Clement J McDonald.   

Abstract

PURPOSE: The utility of National Drug Codes (NDCs) and drug knowledge bases (DKBs) in the organization of prescription records from multiple sources was studied.
METHODS: The master files of most pharmacy systems include NDCs and local codes to identify the products they dispense. We obtained a large sample of prescription records from seven different sources. These records carried a national product code or a local code that could be translated into a national product code via their formulary master. We obtained mapping tables from five DKBs. We measured the degree to which the DKB mapping tables covered the national product codes carried in or associated with the sample of prescription records.
RESULTS: Considering the total prescription volume, DKBs covered 93.0-99.8% of the product codes from three outpatient sources and 77.4-97.0% of the product codes from four inpatient sources. Among the in-patient sources, invented codes explained 36-94% of the noncoverage. Outpatient pharmacy sources rarely invented codes, which comprised only 0.11-0.21% of their total prescription volume, compared with inpatient pharmacy sources for which invented codes comprised 1.7-7.4% of their prescription volume. The distribution of prescribed products was highly skewed, with 1.4-4.4% of codes accounting for 50% of the message volume and 10.7-34.5% accounting for 90% of the message volume.
CONCLUSION: DKBs cover the product codes used by outpatient sources sufficiently well to permit automatic mapping. Changes in policies and standards could increase coverage of product codes used by inpatient sources.

Entities:  

Mesh:

Year:  2009        PMID: 19767382      PMCID: PMC2965522          DOI: 10.2146/ajhp080221

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  8 in total

1.  Evaluation of a proposed method for representing drug terminology.

Authors:  J J Cimino; T J McNamara; T Meredith; C A Broverman; K C Eckert; M Moore; D J Tyree
Journal:  Proc AMIA Symp       Date:  1999

2.  A semantic normal form for clinical drugs in the UMLS: early experiences with the VANDF.

Authors:  Stuart J Nelson; Steven H Brown; Mark S Erlbaum; Nels Olson; Tammy Powell; Brian Carlsen; John Carter; Mark S Tuttle; William T Hole
Journal:  Proc AMIA Symp       Date:  2002

3.  Analysis of identifier performance using a deterministic linkage algorithm.

Authors:  Shaun J Grannis; J Marc Overhage; Clement J McDonald
Journal:  Proc AMIA Symp       Date:  2002

4.  Design and implementation of an application and associated services to support interdisciplinary medication reconciliation efforts at an integrated healthcare delivery network.

Authors:  Eric G Poon; Barry Blumenfeld; Claus Hamann; Alexander Turchin; Erin Graydon-Baker; Patricia C McCarthy; John Poikonen; Perry Mar; Jeffrey L Schnipper; Robert K Hallisey; Sandra Smith; Christine McCormack; Marilyn Paterno; Christopher M Coley; Andrew Karson; Henry C Chueh; Cheryl Van Putten; Sally G Millar; Margaret Clapp; Ishir Bhan; Gregg S Meyer; Tejal K Gandhi; Carol A Broverman
Journal:  J Am Med Inform Assoc       Date:  2006 Nov-Dec       Impact factor: 4.497

5.  Health care IT collaboration in Massachusetts: the experience of creating regional connectivity.

Authors:  John Halamka; Meg Aranow; Carl Ascenzo; David Bates; Greg Debor; John Glaser; Allan Goroll; Jim Stowe; Micky Tripathi; Gordon Vineyard
Journal:  J Am Med Inform Assoc       Date:  2005-07-27       Impact factor: 4.497

6.  Assessing the impact of HL7/FDA Structured Product Label (SPL) content for medication knowledge management.

Authors:  Gunther Schadow
Journal:  AMIA Annu Symp Proc       Date:  2007-10-11

7.  The need for a concept-based medication vocabulary as an enabling infrastructure in health informatics.

Authors:  W D Sperzel; C A Broverman; J E Kapusnik-Uner; J M Schlesinger
Journal:  Proc AMIA Symp       Date:  1998

8.  The Indiana network for patient care: a working local health information infrastructure. An example of a working infrastructure collaboration that links data from five health systems and hundreds of millions of entries.

Authors:  Clement J McDonald; J Marc Overhage; Michael Barnes; Gunther Schadow; Lonnie Blevins; Paul R Dexter; Burke Mamlin
Journal:  Health Aff (Millwood)       Date:  2005 Sep-Oct       Impact factor: 6.301

  8 in total
  6 in total

1.  Cross-terminology mapping challenges: a demonstration using medication terminological systems.

Authors:  Himali Saitwal; David Qing; Stephen Jones; Elmer V Bernstam; Christopher G Chute; Todd R Johnson
Journal:  J Biomed Inform       Date:  2012-06-28       Impact factor: 6.317

2.  Approaches to Supporting the Analysis of Historical Medication Datasets with RxNorm.

Authors:  Lee B Peters; Olivier Bodenreider
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

3.  Variability in drug formularies and implications in decision support.

Authors:  Matthew J Stephens; John T Finnell; Linas Simonaitis; J Marc Overhage
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

4.  Protecting patients in health information exchange: a defense of the HIPAA privacy rule.

Authors:  Clement McDonald
Journal:  Health Aff (Millwood)       Date:  2009 Mar-Apr       Impact factor: 6.301

5.  The Drug Data to Knowledge Pipeline: Large-Scale Claims Data Classification for Pharmacologic Insight.

Authors:  Mark L Homer; Nathan P Palmer; Olivier Bodenreider; Aurel Cami; Laura Chadwick; Kenneth D Mandl
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2016-07-20

6.  Enhancing the drug ontology with semantically-rich representations of National Drug Codes and RxNorm unique concept identifiers.

Authors:  Jonathan P Bona; Mathias Brochhausen; William R Hogan
Journal:  BMC Bioinformatics       Date:  2019-12-23       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.